RIO DE JANEIRO, BRAZIL - The country's health regulator Anvisa approved the technology used in the United States and Europe at the cost of almost R$20,000 (US$3,700). The Diabetes Association Brazil says it will ask the Ministry of Health to evaluate the device's supply through SUS.
The first implant of an artificial pancreas in Brazil was performed on a Curitiba woman who had diabetes.
Larissa, 30, has type 1 diabetes when the body stops producing insulin or produces a minimal amount. Because of this, she has to wake up several times at night to do . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here